Publicacións nas que colabora con Francisco Barros Angueira (23)

2024

  1. Genetic linkage analysis of head and neck cancer in a Spanish family

    Oral Diseases, Vol. 30, Núm. 3, pp. 1032-1039

2019

  1. Novel truncating variants expand the phenotypic spectrum of KAT6B-related disorders

    American Journal of Medical Genetics, Part A, Vol. 179, Núm. 2, pp. 290-294

2018

  1. Determination and diagnostic value of CA9 mRNA in peripheral blood of patients with oral leukoplakia

    Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 33, Núm. 1, pp. 951-955

  2. Hypomyelinating leukodystrophy type 6. Clinical and neuroimaging key features in the detection of a new case

    Revista de Neurologia, Vol. 67, Núm. 9, pp. 339-342

2017

  1. Copy number variation analysis of patients with intellectual disability from North-West Spain

    Gene, Vol. 626, pp. 189-199

2015

  1. Caracterización molecular y descripción fenotípica de dos casos con aberraciones cromosómicas recíprocas en la region de los síndromes de microdeleción/microduplicación 3q29

    Revista de Neurologia, Vol. 61, Núm. 6, pp. 255-260

  2. The loss of p16 expression worsens the prognosis of OSCC

    Applied Immunohistochemistry and Molecular Morphology, Vol. 23, Núm. 10, pp. 724-732

  3. The use of CA-IX as a diagnostic method for oral leukoplakia

    Biotechnic and Histochemistry, Vol. 90, Núm. 2, pp. 124-131

2014

  1. Expression of CA IX in dysplasia adjacent to surgical resection margins of oral squamous cell carcinoma

    Biotechnic and Histochemistry, Vol. 89, Núm. 2, pp. 91-97

  2. Quantitative determination of c-myc facilitates the assessment of prognosis of OSCC patients

    Oncology Reports, Vol. 31, Núm. 4, pp. 1677-1682

2013

  1. Microdeleción 16p11.2 asociada a convulsiones benignas de la primera infancia

    Revista de Neurologia

  2. Microdeleción 2q23.1 y hallazgos sindrómicos

    Revista de Neurologia

  3. The role of p21Waf1/CIP1 as a Cip/Kip type cell-cycle regulator in oral squamous cell carcinoma (Review)

    Medicina Oral, Patologia Oral y Cirugia Bucal, Vol. 18, Núm. 2

2012

  1. Activity of β2-adrenergic receptor in oral squamous cell carcinoma is mediated by overexpression of the ADRBK2 gene: A pilot study

    Biotechnic and Histochemistry, Vol. 87, Núm. 3, pp. 179-186

  2. BCL10 expression is unrelated to clinico-pathological parameters or prognoses for oral squamous cell carcinomas

    Biotechnic and Histochemistry, Vol. 87, Núm. 6, pp. 423-427

  3. Comparison of the Cytobrush ®, dermatological curette and oral CDx ® brush test as methods for obtaining samples of RNA for molecular analysis of oral cytology

    Cytopathology, Vol. 23, Núm. 3, pp. 192-197

  4. The role of the adenomatous polyposis coli (APC) in oral squamous cell carcinoma

    Oral Oncology, Vol. 48, Núm. 1, pp. 56-60

  5. Tissue inhibitor of metalloproteinases in oral squamous cell carcinomas - A therapeutic target?

    Cancer Letters

  6. Uma atualização na estrutura, função e regulação das V-ATPases: O papel das subunidades C

    Brazilian Journal of Biology, Vol. 72, Núm. 1, pp. 189-198

2011

  1. P16INK4a/CDKN2 expression and its relationship with oral squamous cell carcinoma is our current knowledge enough?

    Cancer Letters